Search papers, labs, and topics across Lattice.
This paper introduces AbLWR, a novel framework for predicting antibody-antigen binding affinity by reformulating it as a listwise ranking problem to address label sparsity. AbLWR employs positive-unlabeled (PU) learning with a dual-level contrastive objective and meta-optimized label refinement to learn robust representations, and uses multi-head self-attention to model inter-sample relationships for handling antigenic variation. Experiments show AbLWR outperforms state-of-the-art baselines, improving Precision@1 by over 10% and demonstrating practical utility in case studies on Influenza and IL-33.
Overcome the data scarcity that plagues antibody-antigen binding affinity prediction with a new method that turns the problem into a ranking task and improves top-candidate precision by 10%.
Accurate prediction of antibody-antigen binding affinity is fundamental to therapeutic design, yet remains constrained by severe label sparsity and the complexity of antigenic variations. In this paper, we propose AbLWR (Antibody-antigen binding affinity List-Wise Ranking), a novel framework that reformulates the conventional affinity regression task as a listwise ranking problem. To mitigate label sparsity, AbLWR incorporates a PU (Positive-Unlabeled) learning mechanism leveraging a dual-level contrastive objective and meta-optimized label refinement to learn robust representations. Furthermore, we address antigenic variation by employing a homologous antigen sampling strategy where Multi-Head Self-Attention (MHSA) explicitly models inter-sample relationships within training lists to capture subtle affinity nuances. Extensive experiments demonstrate that AbLWR significantly outperforms state-of-the-art baselines, improving the Precision@1 (P@1) by over 10$\%$ in randomized cross-validation experiments. Notably, case studies on Influenza and IL-33 validate its practical utility, demonstrating robust ranking consistency in distinguishing subtle viral mutations and efficiently prioritizing top-tier candidates for wet-lab screening.
